Daiichi Sankyo Europe GmbH

Featured Stories

For the last eight years Daiichi Sankyo has supported young graduates in Pharmaceutical Sciences from the Ludwig-Maximilians-University in Munich (LMU). In 2016 Martina Meßner was awarded the "Master Prize" read more...

The new Daiichi Sankyo Group’s Value Report is now available! The report includes business facts & figures, information about Daiichi Sankyo’s growth potential, CSR activities and much more. read more...

Featured News

Date	Description
18/07/2017 Research	Zymeworks and Daiichi Sankyo Announce Successful Achievement of a Research Milestone in Bispecific Antibody Collaboration	PDF
17/07/2017 Products	CHMP Issues a Positive Opinion for Daiichi Sankyo’s Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion	PDF
13/07/2017 Research	Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaboration	PDF
10/07/2017 Products	Daiichi Sankyo Announces New Analyses of Once-Daily LIXIANA® (edoxaban) to be Presented at the ISTH 2017 Congress	PDF
11/05/2017 Research	Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation	PDF
show all

Dear User, This website provides you with information only for healthcare professionals. According to the drug promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have full access to our website. To visit our page please login.

Daiichi Sankyo
Doc Check

Support for Young Talents

Value Report 2016